To determine whether an additional loss of the coagulation factor VII (FVII) gene influenced the coagulopathy observed in protein C gene-deficient (PC -/-) embryos and neonates, we crossed mice doubly heterozygous for the factor VII (FVII +/-) and protein C (PC +/-) genes to produce offspring possessing the 9 predicted genotypic combinations. FVII -/-/PC -/-embryos, although present at their expected Mendelian frequency, displayed a phenotype that had not been observed in either the FVII or PC singly deficient embryos. At E12.5 days postcoitum (dpc), FVII -/-/PC -/-embryos demonstrated an intra-and extravascular coagulopathy that progressed with substantial concomitant hemorrhage and peripheral edema by E17.5dpc, resulting in mortality immediately after birth. FVII +/-/PC -/-embryos showed a less severe phenotype, suggesting a gene dosage effect. The lack of rescue of PC -/-embryos and neonates and augmented coagulopathy resulting from an additional heterozygous or homozygous FVII deficiency are probably due to increased factor Xa and thrombin generation, resulting from loss of FVIIa-dependent tissue factor pathway inhibitor function and the absence of control at the levels of factors Va and VIIIa. The presence of fibrin in embryos in the absence of fetal FVII suggests that significant clot-generating potential exists outside of the embryonic factor VII-dependent pathway.
Murine FVII, PC, and TFPI deficiencies have been generated through targeted total deletion of the FVII (11) and PC (12) genes, and deletion of the first Kunitz domain of TFPI, which is responsible for TFPI/FVIIa interaction (13) . FVII-deficient mice (FVII -/-) developed normally through embryogenesis, but succumbed to perinatal hemorrhage after birth (11) . PC-deficient (PC -/-) embryos demonstrated a coagulopathic phenotype that resulted in their deaths immediately after birth (12) . TFPI-Kunitz 1 domain-deficient mice (TFPI δ/δ ) succumbed to coagulopathy with mortality from E9.5dpc to birth (13, 14) . The latter 2 phenotypes underscore the importance of these anticoagulants during embryogenesis.
Generation of mice with combined deficiencies can provide significant insight into the pathology of individual gene deletion phenotypes and thus further delineate the functions of these proteins. A previous study demonstrated that with deficiency of FVII, the coagulopathy observed in the TFPI δ/δ embryos was ameliorated, verifying the cause of death in these embryos to be solely dependent on its anticoagulant function (14) . In the present case, we hypothesized that if the early mortality associated with PC deficiency in neonates was solely related to a hypercoagulable state, then removal of the primary initiation event of coagulation, namely FVII, could be sufficient to rescue the observed coagulopathy in PC -/-embryos and neonates. Any rescue of the PC -/-neonates would then result in a phenotype similar to the bleeding tendencies observed in the FVII -/-mice. Conversely, if an additional deficiency in FVII did not rescue the PC -/-phenotype, the inference would be that either the early mortality observed in PC -/-neonates was not entirely due to a heightened coagulative state, or that in the absence of FVII, the functioning of the intrinsic pathway or other novel fibrin-generating processes is observed. To test these hypotheses, FVII +/-/PC +/-mice were generated and crossbred to provide FVII -/-/PC -/-animals. The phenotypic analysis of progeny resulting from this breeding is the subject of the current report.
Methods
Animals. The generation of mice heterozygous for the FVII (11) and PC genes (12) has been described. FVII gene deletion results in replacement of exons 2-8 of the FVII gene with a neomycin phosphotransferase (neo) gene, thus eliminating its entire coding region. Targeted replacement of the PC allele results in the deletion of all translatable exons, by substitution of exons 2-9 of the PC gene with the neo gene. Both transgenic lines were backcrossed to the F 4 generation in C57BL/6 mice (∼94% C57BL/6 background). Mice doubly heterozygous for FVII and PC (FVII +/-/PC +/-), which were then bred to generate the animals studied herein, were generated by crossing these F 4 generation FVII +/-and PC +/-mice.
Genotypic analysis. Tail tips, or portions of embryonic tissue or yolk sac, were isolated for the extraction of genomic DNA, as described previously (15 Timed matings. Females were placed with nonsibling males in the late afternoon, and the morning of vaginal plug detection was assigned E0.5dpc. Pregnant females were euthanized, and the embryos were harvested at E12.5dpc, E14.5dpc, and E17.5dpc. Yolk sacs from early-stage embryos or tails of later-stage embryos were dissected for DNA isolation and genotyping.
Histology. Embryos were dissected free of maternal tissue. E12.5dpc and E14.5dpc embryos were fixed whole in freshly prepared 1% phosphate-buffered paraformaldehyde. Organs from E17.5dpc embryos were dissected and fixed similarly. Samples were dehydrated, embedded in paraffin, and sectioned at 4 µm according to standard protocols. Sections were stained with hematoxylin and eosin (H&E) to examine general tissue and cellular morphology, and with Masson's trichrome for detection of collagen (17) . Immunostaining was also carried out on fixed tissues by direct immunoperoxidase or ABC-immunoperoxidase (DAKO A/S, Copenhagen, Denmark) based staining, using commercial peroxidaselabeled murine primary antibodies, or indirectly, using peroxidase-labeled anti-IgG to label primary murine antigen-antibody complexes. Anti-fibrinogen antibody was purchased from Accurate Chemical and Scientific Corp. (Westbury, New York, USA). Anti-P-selectin, CD45, and Mac-3 antibodies were purchased from PharMingen (San Diego, CA). For immunostaining, epitope retrieval was accomplished by incubating sections in antigen retrieval buffer (DAKO A/S).
Results

Generation of FVII +/-/PC +/-mice and progeny from doubleheterozygous crosses.
Mice carrying the FVII +/-genotype were crossed with those with the PC +/-genotype to generate doubly heterozygous animals. Mice possessing the combined FVII +/-/PC +/-genotype appeared healthy and bred normally.
Nonsibling FVII +/-/PC +/-mice were crossed to generate progeny with the 9 genotypes possible from a double-heterozygous cross (Table 1) . Postnatal genotypic analysis of these litters (n = 108) indicated that FVII -/-PC +/+ and FVII -/-/PC +/-mice succumbed to the same intra-abdominal and intracranial hemorrhage that has been observed in FVII -/-mice (11) . Similarly, FVII +/+ /PC -/-(6 observed, 9 expected) and FVII +/-/PC -/-(8 observed, 16 expected) mice were born, but succumbed to the same consumptive coagulopathy observed in the PC -/-mice (12). Thus, the increased C57BL/6 genetic contribution (94% vs. 50% in both original studies), did not alter the phenotype of these F 4 animals. However, no FVII -/-/PC -/-neonates were identified (0 observed, 8 expected), possibly indicating that the combined FVII/PC deficiency resulted in embryonic lethality not previously observed in either of the FVII or PC single deficiencies. In addition, it was not conclusive whether a 50% level of FVII altered the survival or phenotype of the PC-deficient neonates. Thus, timed matings were initiated to harvest embryos at specific ages (Table 1) .
Characterization of E17.5dpc embryos from double-heterozygous matings. Contrary to the postnatal genotypic analysis, at E17.5dpc, FVII -/-/PC -/-embryos were present at their expected Mendelian frequency (5/93) at E17.5dpc (Table 1) . However, initial examination of these embryos demonstrated a phenotype that had clearly not been observed in either of the single FVII or PC gene deficiencies. Four of these 5 embryos were alive, but demonstrated severe edema, anemia, subcutaneous bleeding at the joints, and peripheral bleeding, as well as necrosis around the nasal area (Figure 1a) . Although blood was also observed between the yolk sac and the embryo, yolk sac development and blood flow was normal (data not shown). In addition, placentas did not demonstrate abnormal development or hemorrhage. Unfortunately, the extensive hemorrhaging in the embryo prevented the collection of blood by direct cardiac puncture. Upon closer examination of the organs, fibrotic patches were observed in the liver, the brain demonstrated variable bleeding and necrosis, the ventricles were anemic, and the atria were clotted. These characteristics were also observed in the PC singly deficient littermates. In 1 case, bleeding was also evident in the stomach and intestinal tract. H&E staining verified the patches of liver fibrosis, encompassing red blood cell extravasation in the interstitia ( Figure  1b) . Interstitial fibrin deposition was also clearly evident in areas surrounding these fibrotic lesions ( Figure  1c ). Brain sections that were similarly stained demonstrated variable necrosis, massive hemorrhage, and fibrin deposition (Figure 1, d and e) . Staining for collagen was positive in these areas, indicating the invasion of scar tissue, probably designed to contain hemorrhage and tissue damage (Figure 1f) . Additionally, nonmacrophage CD45 + leukocytes were located in these areas of nonvascular fibrin deposition (Figure 1g ). Similar to the observations in the brain, macroscopic characteristics of the atria were confirmed with H&E and antifibrin immunostaining. Abnormal hemorrhage and fibrin deposition was observed, as was the presence of abnormal collagen invasion in the internal atrial tissue ( Figure 1 Thus, it appears that a 50% level of FVII does not significantly alter the coagulopathy observed in PC-deficient embryos. Additionally, these embryos were present at their expected Mendelian frequency, suggesting that their underrepresentation postnatally (Table 1) was due to our inability to identify these neonates before their death and consumption by their parents.
Characterization of E14.5dpc embryos from double-heterozygous matings. The progression of the coagulopathy in FVII -/-PC -/-embryos could be observed as early as E14.5dpc. Although PC -/-embryos appeared relatively normal with minimal bleeding anomalies, all FVII -/-/PC -/-embryos (5 out of 59 total embryos) exhibited peripheral and internal bleeding, with concomitant anemia (Figure 2a ). Yolk sac development and blood flow generally appeared normal; however, 1 FVII -/-/PC -/-embryo demonstrated blood pools within the amniotic sac. Extensive peripheral bleeding and fibrin deposition were confirmed histologically ( Figure 2, b and c) . Fibrin deposition, hemorrhage, and tissue degradation was also observed in the brain (Figure 2d ), along the spine (Figure 2e) , and in the liver. As with the E17.5dpc FVII -/-/PC -/-embryos, blood could not be collected by intracardiac puncture due to massive hemorrhaging. Of the 7 FVII +/-/PC -/-embryos examined at this age, 2 demon- strated variable bleeding spots on the skin and blood pools within the amniotic sac. Interstitial fibrin deposition was observed in the livers, and to a lesser extent, in the brains of these embryos, but there was no evidence of the peripheral or organ hemorrhage that was observed in the FVII -/-/PC -/-embryos (data not shown).
Characterization of E12.5dpc embryos from double-heterozygous matings.
In contrast to the E14.5dpc and E17.5dpc time points, E12.5dpc FVII -/-/PC -/-embryos appeared developmentally normal, with no obvious external bleeding anomalies. Histologically, however, fibrin deposition, in the absence of accompanying hemorrhage, was observed in the liver interstitia and in vessels in the brain, neural canal, caudal artery, pulmonary cavity, dorsal aorta, and left hind-limb bud (Figure 3, a and b) . PC -/-embryos also had fibrin deposition in the liver interstitia and in vessels in the brain (data not shown). Again, areas of intra-and extravascular fibrin deposition did not stain positively for Pselectin-positive activated platelets (data not shown).
Discussion
It is generally accepted that thrombin generation and subsequent fibrin clot formation after vascular injury is a result of specific proteolytic events stemming solely from the combined efforts of the FVIIa/TF-initiated extrinsic pathway and the FXIa-initiated intrinsic pathway. Each of these pathways is controlled by specific inhibitors. TFPI attenuates the extrinsic pathway after the initial activation of small amounts of FX to FXa. Antithrombin III (ATIII) and aPC influence the intrinsic and extrinsic pathways through different mechanisms, by inactivating FXa and thrombin (ATIII), and FVa and FVIIIa (aPC). The importance of both TFPI and aPC is underscored by the fact that mice deficient in
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The either TFPI or PC succumb to embryonic coagulopathy resulting in variable survival (12) (13) (14) . These results are not altogether surprising considering that no TFPI-deficient patients have been identified, and that extensive (and often lethal) thrombotic events are observed in humans with homozygotic or compound heterozygotic PC deficiency. Additionally, PC has been regarded as a link between coagulation and inflammation (18) . Although increased neutrophil infiltration was observed in several of the PC -/-embryos at E18.5dpc (12) , an inflammatory-related cause of death was not thoroughly investigated. In a previous study, complete loss of the FVII gene (FVII -/-) resulted in rescue of the embryonic lethality in TFPI-deficient mice, demonstrating that the cause of death in these original TFPI-compromised embryos was due to uncontrolled FVII activity (14) . Accordingly, to further understand the cause of death in PC-deficient mice and to attempt to delineate the roles of PC in vivo, FVII +/-/PC +/-mice were generated and intercrossed to produce doubly deficient progeny. However, in contrast to the FVII/TFPI double gene deletion study, postnatal genotypic analysis of litters produced from FVII +/-/PC +/-crosses did not indicate the presence of FVII -/-/PC -/-animals, suggesting that combined complete FVII/PC gene deficiency is not compatible with neonatal survival. Indeed, harvesting of embryos between E12.5 and E17.5dpc, sired from double-heterozygous crosses, indicated that FVII -/-/PC -/-embryos, although alive and present at their expected Mendelian distribution, presented with an enhanced coagulopathic phenotype not observed in PC-deficient embryos, resulting in elevated peripheral hemorrhage and necrosis of external tissues. Thus, their significant postnatal underrepresentation was due to their immediate death either during or immediately after birth and their ultimate consumption by the parents, a phenomenon observed previously in FVII and PC singly deficient neonates (11, 12) . Histologically, development of intra-and extravascular fibrin deposition began as early as E12.5dpc, which was not observed in the control littermate PC -/-embryos. This coagulopathy resulted in severe extravascular fibrin deposition in the liver, as well as atrial and brain tissue, with concomitant hemorrhage, as seen in the older FVII -/-/ PC -/-embryos. P-selectin-positive immunostaining for the detection of activated platelets was not observed in fibrin-positive occluded vessels at E12.5dpc, nor in areas of extravascular fibrin deposition in later embryogenesis. CD45-positive leukocytes, although not identified as activated macrophages, were located intertwined in areas staining positively with fibrin The fact that fibrin deposition was observed in the complete absence of FVII and PC was surprising. Our initial expectation was that the absence of fetal FVII would result in the loss of the initial burst of thrombin generation required to activate the FXI-initiated intrinsic pathway. Furthermore, the fact that a more severe coagulopathy was observed in PC-deficient embryos, in the absence of fetal FVII, was also unexpected. It is unlikely that the increased coagulopathy in the FVII -/-/PC -/-embryos and neonates was due to the higher C57BL/6 genetic contribution (94% vs. 50% in the original studies), because the phenotypes of the single knockout littermates did not differ from those with a 50% C57BL/6 background studied previously (11, 12) . Instead, a plausible explanation for this heightened coagulopathy in the FVII -/-/PC -/-embryos may be twofold. First, in our model, the absence of the FVII gene may result in the loss of the anticoagulant function of the TFPI inhibitory complex, which requires FVIIa to function (14) . Although in vitro studies have demonstrated that TFPI can bind to and inhibit FXa activity in the absence of FVIIa and TF (19) , a mutant of TFPI lacking its Kunitz 1 domain (the FVIIa binding domain), but still containing its Kunitz 2 domain (the FXa binding domain), could not prevent coagulopathy in vivo (13) . Thus, the functional redundancy afforded by the FXI-initiated intrinsic pathway, previously known as important in the maintenance of thrombin generation, is no longer controlled by either PC (which has been deleted) or TFPI (which is functionally irrelevant). Without this control, levels of FXa and thrombin are generated that can result in excessive amounts of fibrin formation. However, these amounts of thrombin and fibrin are lower due to the absence of FVII. In essence, the (13, 14) . Secondly, increased levels of thrombin, in the absence of PC and TFPI, may result in elevated activation of TAFI, which would serve to downregulate plasmin fibrinolytic activity, tipping the hemostatic balance even further toward an enhanced prothrombotic state. Thirdly, placental transfer of maternal FVII may account for the observed coagulopathy. However, a direct examination of maternal FVII levels in embryos failed to reveal such transfer, except when supraphysiological levels of maternal FVII were present (11, 20) . Additionally, the rescue of the intrauterine lethality associated with a TFPI deficiency by the additional loss of FVII suggests that any possible level of maternal FVII is insufficient to cause coagulopathy in these embryos (14) . Furthermore, if maternal FVII accounts for the total FVII in FVII -/-/PC -/-embryos, then their enhanced coagulopathic phenotype, as compared with their PC -/-littermates, would not be observed. Taken together, although very small (and as yet undetectable by currently available assays) amounts of maternal FVII in embryos could influence other functions of TF, it is highly unlikely that maternal FVII plays a role in the observed combined FVII -/-/PC -/-coagulopathy.
A fourth possible explanation for the incomplete rescue of the PC -/-genotype by the additional loss of FVII is that other novel fibrin-generating mechanisms exist outside of the FXI-initiated intrinsic pathway. Further combined deficiency models will be invaluable in addressing this topic in an in vivo setting.
A final intriguing issue is that activation of the intrinsic pathway appears to be occurring in the absence of FVIIa/TF activity, which has been believed to be the initiator of low-level thrombin generation required to activate FXI and the intrinsic maintenance pathway.
The presence of fibrin in FVII -/-/PC -/-embryos raises the issue of the mechanism of FXI activation in the absence of FVII, if initial thrombin levels are generated through this route, and suggests that other mechanisms are in place to activate FXI in vivo.
